Mangoceuticals (MGRX) Competitors $1.71 +0.03 (+1.79%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$1.68 -0.03 (-2.05%) As of 08/1/2025 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. CCM, MRAI, BRTX, SSY, BGLC, VSEE, DHAC, ACON, ATIP, and OTRKShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Concord Medical Services (CCM), Marpai (MRAI), Biorestorative Therapies (BRTX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), VSee Health (VSEE), Digital Health Acquisition (DHAC), Aclarion (ACON), ATI Physical Therapy (ATIP), and Ontrak (OTRK). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Its Competitors Concord Medical Services Marpai Biorestorative Therapies SunLink Health Systems BioNexus Gene Lab VSee Health Digital Health Acquisition Aclarion ATI Physical Therapy Ontrak Mangoceuticals (NASDAQ:MGRX) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability. Do institutionals and insiders hold more shares of MGRX or CCM? 56.7% of Mangoceuticals shares are owned by institutional investors. 16.0% of Mangoceuticals shares are owned by company insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, MGRX or CCM? Mangoceuticals has a beta of 2.4, meaning that its share price is 140% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.94, meaning that its share price is 194% less volatile than the S&P 500. Which has better valuation and earnings, MGRX or CCM? Mangoceuticals has higher earnings, but lower revenue than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$511.08K17.29-$8.71M-$4.64-0.37Concord Medical Services$52.60M0.50-$42.23MN/AN/A Does the media refer more to MGRX or CCM? In the previous week, Concord Medical Services had 1 more articles in the media than Mangoceuticals. MarketBeat recorded 1 mentions for Concord Medical Services and 0 mentions for Mangoceuticals. Concord Medical Services' average media sentiment score of 1.00 beat Mangoceuticals' score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media. Company Overall Sentiment Mangoceuticals Neutral Concord Medical Services Positive Is MGRX or CCM more profitable? Concord Medical Services has a net margin of 0.00% compared to Mangoceuticals' net margin of -2,191.76%. Concord Medical Services' return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-2,191.76% -72.81% -66.58% Concord Medical Services N/A N/A N/A SummaryConcord Medical Services beats Mangoceuticals on 7 of the 11 factors compared between the two stocks. Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.68M$2.46B$5.49B$9.52BDividend YieldN/A1.81%4.73%4.09%P/E Ratio-0.378.9728.7823.81Price / Sales17.29437.65372.2066.04Price / CashN/A157.7635.4557.96Price / Book0.404.838.275.54Net Income-$8.71M$31.62M$3.25B$259.28M7 Day Performance-1.16%-5.28%-3.70%-4.64%1 Month Performance12.50%4.38%4.34%4.41%1 Year Performance-97.92%-2.49%25.90%17.95% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticalsN/A$1.71+1.8%N/A-98.0%$8.68M$511.08K-0.373Positive NewsCCMConcord Medical Services1.6868 of 5 stars$5.22-4.4%N/A-32.6%$22.66M$52.60M0.00970Positive NewsShort Interest ↓MRAIMarpaiN/A$1.33+1.2%N/A+122.6%$21.93M$34.87M-0.50150Upcoming EarningsGap DownBRTXBiorestorative Therapies3.5123 of 5 stars$1.53-2.5%$18.00+1,076.5%-7.8%$11.48M$400K-1.047SSYSunLink Health Systems1.7222 of 5 stars$1.24-6.1%N/A+22.4%$8.73M$31.09M8.861,376Gap DownBGLCBioNexus Gene Lab0.2249 of 5 stars$4.46-2.0%N/A+43.2%$8.02M$9.27M0.0030News CoverageShort Interest ↑Gap DownVSEEVSee Health1.3512 of 5 stars$1.34+0.8%$5.00+273.1%-50.2%$4.83M$6.38M0.00N/APositive NewsDHACDigital Health AcquisitionN/A$1.33-2.2%N/A-43.8%$4.79MN/A0.002,021Gap UpACONAclarion1.4909 of 5 stars$7.71-1.7%$11,758.50+152,409.7%-99.7%$4.47M$50K0.007ATIPATI Physical Therapy0.1268 of 5 stars$0.68+87.5%N/A-89.1%$2.98M$741.86M-0.045,600News CoverageGap UpOTRKOntrak2.1483 of 5 stars$0.49-6.9%$24.00+4,800.0%-92.0%$2.07M$10.85M-0.03250Upcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies CCM Alternatives MRAI Alternatives BRTX Alternatives SSY Alternatives BGLC Alternatives VSEE Alternatives DHAC Alternatives ACON Alternatives ATIP Alternatives OTRK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
